表紙:体外式膜酸素療法市場- モダリティ別、用途別、患者数別、世界予測、2023年~2032年
市場調査レポート
商品コード
1267471

体外式膜酸素療法市場- モダリティ別、用途別、患者数別、世界予測、2023年~2032年

Extracorporeal Membrane Oxygenation Market - By Modality, By Application, By Patient Population & Global Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
体外式膜酸素療法市場- モダリティ別、用途別、患者数別、世界予測、2023年~2032年
出版日: 2023年04月05日
発行: Global Market Insights Inc.
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外式膜酸素療法(ECMO)の世界市場は、欧州における政府の取り組みやプログラムの増加により、2032年まで大きく成長すると予測されています。

欧州では近年、呼吸器系疾患と循環器系疾患の有病率が大幅に増加しており、この動向は予測期間中も続くと予想されます。CVD患者の増加により、政府の施策が導入され、国民の意識を高めるためのさまざまなプログラムが実施されています。新興国におけるインフラ整備のための政府資金援助は、高価な機械をより身近なものにすることにつながり、業界の収益成長を後押しすることになるでしょう。

例えば、2021年1月、Braile Biomedicaは、Eldorado InstituteおよびEmbrapiiと共同で、COVID-19に対する全国規模の製品であるSOLIS Systemを発表しました。体外呼吸の一種であるECMO(Extracorporeal membrane oxygenation)がこのシステムを構成しています。このような製品のイントロダクションより、同企業は市場での地位を確保することができました。

ECMO市場は、アプローチ、タイプ、患者数、地域の観点から分けられています。

アプローチに基づくと、静脈(VV)セグメントは2022年に1億8,000万米ドル以上を保有しました。静脈ECMO装置は、血流と酸素濃度を増加させながら、心臓への負担を軽減し、血行動態をサポートする装置です。心肺疾患の負担増により、予測期間中、静脈ECMOの需要が増加すると思われます。

タイプ別では、呼吸器分野が2023年から2032年にかけて3%以上のCAGRで成長すると予測されています。このセグメントの成長の重要な要因は、さまざまな呼吸器疾患を持つ個人の間で呼吸不全のリスクがあることです。また、呼吸器系の病気にかかりやすい老年人口が拡大していることも、成長する市場環境をさらに補完するものと思われます。

患者層別では、成人層が予測期間を通じて積極的な市場拡大を予見しています。ECMO治療のニーズは、高齢者人口の増加、感染症や慢性疾患の患者数の増加によってもたらされるでしょう。また、成人患者を治療するためのECMO技術の進歩が、業界の拡大に寄与すると考えられます。

地域別では、ラテンアメリカの体外式膜酸素療法(ECMO)市場は、2023年から2032年にかけてCAGR4%以上で成長すると推定されます。これは、中南米諸国のヘルスケア環境における最先端のECMO技術の利用が急増していることに加え、同地域の呼吸器疾患や心臓疾患の発生率が上昇していることが要因です。さらに、この地域の拡大は、COVID-19の影響を受けた国々におけるECMOデバイスの需要増加からも恩恵を受けることになります。

目次

第1章 調査手法

  • 調査手法
  • 市場の範囲と定義
  • 基本推定と計算結果
  • 予測計算
  • データバリデーション
  • データソース
    • 1次データ
    • 2次データ
      • 有償ソース
      • 未払いソース

第2章 エグゼクティブサマリー

第3章 体外式膜酸素療法の業界洞察

  • 業界情勢、2018-2032年
  • 業界への影響要因
    • 促進要因
      • アジア太平洋地域における心肺疾患や呼吸不全の症例の増加
      • ECMOデバイスの技術的進歩
      • ラテンアメリカにおける体外式膜酸素療法の利点に対する患者の意識の高まり
      • 欧州における政府の取り組みやプログラムの増加
    • 業界の潜在的リスク&課題
      • 高い機材費
      • 熟練したプロフェッショナルの不足
      • ECMO装置に関するリスク
  • 成長性分析
    • モダリティ別
    • 用途別
    • 患者層別
  • COVID-19影響分析
  • 規制状況について
    • 米国
    • 欧州
  • ECMO処置量、地域別
  • ポーター分析
  • PESTEL分析

第4章 競合情勢について

  • イントロダクション
  • 競合ダッシュボード、2021年
  • 各社の市場シェア(2021年
  • 主要市場プレイヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略的展望マトリクス

第5章 体外式膜酸素療法市場:モダリティ別

  • 主なセグメント動向
  • Venoarterial(VA)
  • 静脈型(VV)
  • 動静脈(AV)

第6章 体外式膜酸素療法市場:用途別

  • 主なセグメント動向
  • 心臓疾患
  • 呼吸器系疾患
  • 体外式心肺蘇生法(ECPR)

第7章 体外式膜酸素療法市場:患者層別

  • 主なセグメント動向
  • 乳幼児
  • 小児科
  • アダルト

第8章 体外式膜酸素療法市場:地域別

  • 主な地域動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 台湾
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ地域
    • 南アフリカ
    • サウジアラビア
    • カタール
    • UAE

第9章 企業プロファイル

  • Abbott Laboratories
  • Fresenius Medical Care AG & Co. KGaA
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Abiomed, Eurosets
  • Getinge AB
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro
  • SB-Kawasumi Laboratories, Inc.
  • Spectrum Medical, Terumo Corporation
図表

Data Tables

  • TABLE 1 ECMO market, 2018 - 2024 (USD Million)
  • TABLE 2 ECMO market, 2025 - 2032 (USD Million)
  • TABLE 3 ECMO market, by modality, 2018 - 2024 (USD Million)
  • TABLE 4 ECMO market, by modality, 2025 - 2032 (USD Million)
  • TABLE 5 ECMO market, by application, 2018 - 2024 (USD Million)
  • TABLE 6 ECMO market, by application, 2025 - 2032 (USD Million)
  • TABLE 7 ECMO market, by patient population, 2018 - 2024 (USD Million)
  • TABLE 8 ECMO market, by patient population, 2025 - 2032 (USD Million)
  • TABLE 9 ECMO market, by region, 2018 - 2024 (USD Million)
  • TABLE 10 ECMO market, by region, 2025 - 2032 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Number of ECMO procedures, by region, 2018-2024
  • TABLE 13 Number of ECMO procedures, by region, 2025-2032
  • TABLE 14 Venoarterial (VA) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 15 Venoarterial (VA) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 16 Veno-venous (VV) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 17 Veno-venous (VV) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 18 Arteriovenous (AV) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 19 Arteriovenous (AV) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 20 Cardiac disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 21 Cardiac disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 22 Respiratory disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 23 Respiratory disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 24 ECPR market size, by region, 2018 - 2024 (USD Million)
  • TABLE 25 ECPR market size, by region, 2025 - 2032 (USD Million)
  • TABLE 26 Infant market size, by region, 2018 - 2024 (USD Million)
  • TABLE 27 Infant market size, by region, 2025 - 2032 (USD Million)
  • TABLE 28 Pediatric disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 29 Pediatric disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 30 Adult disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 31 Adult disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 32 North America ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 33 North America ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 34 North America ECMO market size, by Product, 2018 - 2024 (USD Million)
  • TABLE 35 North America ECMO market size, by product, 2025 - 2032 (USD Million)
  • TABLE 36 North America ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 37 North America ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 38 North America ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 39 North America ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 40 North America ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 41 North America ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 42 U.S. ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 43 U.S. ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 44 U.S. ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 45 U.S. ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 46 U.S. ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 47 U.S. ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 48 Canada ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 49 Canada ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 50 Canada ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 51 Canada ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 52 Canada ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 53 Canada ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 54 Europe ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 55 Europe ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 56 Europe ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 57 Europe ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 58 Europe ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 59 Europe ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 60 Europe ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 61 Europe ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 62 Germany ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 63 Germany ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 64 Germany ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 65 Germany ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 66 Germany ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 67 Germany ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 68 UK ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 69 UK ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 70 UK ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 71 UK ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 72 UK ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 73 UK ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 74 France ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 75 France ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 76 France ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 77 France ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 78 France ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 79 France ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 80 Italy ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 81 Italy ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 82 Italy ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 83 Italy ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 84 Italy ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 85 Italy ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 86 Spain ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 87 Spain ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 88 Spain ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 89 Spain ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 90 Spain ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 91 Spain ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 92 Asia Pacific ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 93 Asia Pacific ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 94 Asia Pacific ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 95 Asia Pacific ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 96 Asia Pacific ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 97 Asia Pacific ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 98 Asia Pacific ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 99 Asia Pacific ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 100 India ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 101 India ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 102 India ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 103 India ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 104 India ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 105 India ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 106 China ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 107 China ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 108 China ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 109 China ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 110 China ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 111 China ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 112 Japan ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 113 Japan ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 114 Japan ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 115 Japan ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 116 Japan ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 117 Japan ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 118 Taiwan ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 119 Taiwan ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 120 Taiwan ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 121 Taiwan ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 122 Taiwan ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 123 Taiwan ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 124 Latin America ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 125 Latin America ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 126 Latin America ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 127 Latin America ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 128 Latin America ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 129 Latin America ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 130 Latin America ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 131 Latin America ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 132 Brazil ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 133 Brazil ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 134 Brazil ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 135 Brazil ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 136 Brazil ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 137 Brazil ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 138 Mexico ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 139 Mexico ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 140 Mexico ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 141 Mexico ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 142 Mexico ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 143 Mexico ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 144 Argentina ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 145 Argentina ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 146 Argentina ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 147 Argentina ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 148 Argentina ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 149 Argentina ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 150 Middle East & Africa ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 151 Middle East & Africa ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 152 Middle East & Africa ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 153 Middle East & Africa ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 154 Middle East & Africa ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 155 Middle East & Africa ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 156 Middle East & Africa ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 157 Middle East & Africa ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 158 South Africa ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 159 South Africa ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 160 South Africa ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 161 South Africa ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 162 South Africa ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 163 South Africa ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 164 Saudi Arabia ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 165 Saudi Arabia ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 166 Saudi Arabia ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 167 Saudi Arabia ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 168 Saudi Arabia ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 169 Saudi Arabia ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 170 Qatar ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 171 Qatar ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 172 Qatar ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 173 Qatar ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 174 Qatar ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 175 Qatar ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 176 UAE ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 177 UAE ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 178 UAE ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 179 UAE ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 180 UAE ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 181 UAE ECMO market size, by patient population, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG 1 Industry segmentation
  • FIG 2 Global extracorporeal membrane oxygenation market, 2018 - 2032 (USD Million)
  • FIG 3 Industry ecosystem
  • FIG 4 Growth potential analysis, by modality
  • FIG 5 Growth potential analysis, by application
  • FIG 6 Growth potential analysis, by patient population
  • FIG 7 Porter's analysis
  • FIG 8 PESTEL analysis
  • FIG 9 Key segment trends, by modality
  • FIG 10 Key segment trends, by application
  • FIG 11 Key segment trends, by patient population
  • FIG 12 Strategy dashboard
目次
Product Code: 2720

The global extracorporeal membrane oxygenation (ECMO) market is speculated to grow significantly through 2032 owing to increasing government initiatives as well as programs in Europe.

The prevalence of respiratory and cardiovascular illnesses has increased dramatically throughout the European region in recent years, and this trend is expected to continue over the forecast time. An increase in CVD cases has led to introduction of government measures and implementation of different programs in the area to raise public awareness. Government funding for infrastructure development in emerging nations would help make expensive machines more accessible, which will boost industry revenue growth.

For instance, in January 2021, Braile Biomedica, in collaboration with the Eldorado Institute and Embrapii, introduced the SOLIS System, a nationwide product against COVID-19. Extracorporeal membrane oxygenation (ECMO), a type of extracorporeal breathing, makes up the system. The corporation has benefited from such product introductions in securing its market position.

The ECMO market has been divided in terms of approach, type, patient population, and region.

Based on approach, the veno-venous (VV) segment held more than $180 million in 2022. The veno-venous ECMO device increases blood flow and oxygen levels while reducing cardiac effort and supporting hemodynamics. There will likely be a rise in demand for veno-venous ECMO through the forecast years due to the growing burden of cardiopulmonary diseases.

With respect to type, the respiratory segment is poised to grow at more than 3% CAGR from 2023 to 2032. A significant factor in the segment's growth is the risk of respiratory failure among individuals with different respiratory illnesses. Besides, the expanding geriatric population that is vulnerable to respiratory ailments, would further complement the growing market landscape.

In terms of the patient population, the adult segment is projected to foresee positive market expansion through the forecast years. The need for ECMO treatments will be driven by the growing elderly population base and the rise in the number of people with infectious and chronic diseases. Moreover, advancements in ECMO technology for treating adults is likely to contribute to the industry expansion.

From the regional front, the Latin America extracorporeal membrane oxygenation (ECMO) market is estimated to grow at more than 4% CAGR from 2023 to 2032. The expansion is fueled by the burgeoning use of cutting-edge ECMO technology in healthcare settings in LATAM nations along with the region's rising respiratory and cardiac disease rates. Additionally, the regional expansion will also benefit from the increased ECMO device demand in the COVID-19-affected nations.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Extracorporeal membrane oxygenation industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Modality trends
    • 2.1.3 Application trends
    • 2.1.4 Patient population trends
    • 2.1.5 Regional trends

Chapter 3 Extracorporeal Membrane Oxygenation Industry Insights

  • 3.1 Industry landscape, 2018-2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in cases of cardiopulmonary disease and respiratory failure in Asia Pacific
      • 3.2.1.2 Technological advancements in ECMO devices
      • 3.2.1.3 Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation devices in Latin America
      • 3.2.1.4 Rising government initiatives and programs in Europe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of equipment
      • 3.2.2.2 Dearth of skilled professionals
      • 3.2.2.3 Risks related to ECMO device
  • 3.3 Growth potential analysis
    • 3.3.1 By modality
    • 3.3.2 By application
    • 3.3.3 By patient population
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 ECMO procedure volume, by region
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company market share, 2021
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic outlook matrix

Chapter 5 Extracorporeal Membrane Oxygenation Market, By Modality

  • 5.1 Key segment trends
  • 5.2 Venoarterial (VA)
    • 5.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 5.3 Veno-venous (VV)
    • 5.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 5.4 Arteriovenous (AV)
    • 5.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation Market, By Application

  • 6.1 Key segment trends
  • 6.2 Cardiac diseases
    • 6.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 6.3 Respiratory diseases
    • 6.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 6.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
    • 6.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation Market, By Patient Population

  • 7.1 Key segment trends
  • 7.2 Infant
    • 7.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 7.3 Pediatric
    • 7.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 7.4 Adult
    • 7.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 8 Extracorporeal Membrane Oxygenation Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Taiwan
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Qatar
    • 8.6.4 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Fresenius Medical Care AG & Co. KGaA
  • 9.3 Braile Biomedica
  • 9.4 Edwards Lifesciences Corporation
  • 9.5 Abiomed, Eurosets
  • 9.6 Getinge AB
  • 9.7 LivaNova PLC
  • 9.8 Medtronic
  • 9.9 MicroPort Scientific Corporation
  • 9.10 Nipro
  • 9.11 SB-Kawasumi Laboratories, Inc.
  • 9.12 Spectrum Medical, Terumo Corporation